Harvard Bioscience Inc
NASDAQ:HBIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Harvard Bioscience Inc
NASDAQ:HBIO
|
US |
|
Chandra Asri Petrochemical Tbk PT
IDX:TPIA
|
ID |
|
Gecina SA
OTC:GECFF
|
FR |
|
Farmers Edge Inc
TSX:FDGE
|
CA |
|
Align Technology Inc
NASDAQ:ALGN
|
US |
|
B
|
Barrick Gold Corp
XHAM:ABR
|
CA |
|
N
|
NSL Foods PCL
SET:NSL
|
TH |
|
E
|
Energy Resources Of Australia Ltd
OTC:EGRAF
|
AU |
|
Bank of Nova Scotia
TSX:BNS
|
CA |
|
MorphoSys AG
XETRA:MOR
|
DE |
|
China Shipbuilding Industry Co Ltd
SSE:601989
|
CN |
|
ACS Actividades de Construccion y Servicios SA
OTC:ACSAY
|
ES |
|
Olin Corp
NYSE:OLN
|
US |
|
T
|
Terreno Resources Corp
XTSX:TNO.H
|
CA |
|
Eshallgo Inc
NASDAQ:EHGO
|
CN |
|
Genmab A/S
CSE:GMAB
|
DK |
|
W
|
West Fraser Timber Co Ltd
DUS:WFC
|
CA |
|
Garofalo Health Care SpA
MIL:GHC
|
IT |
|
Marvel Discovery Corp
XTSX:MARV
|
CA |
|
S
|
Shenyang Fortune Precision Equipment Co Ltd
SSE:688409
|
CN |
|
Cosmo Advanced Materials & Technology Co Ltd
KRX:005070
|
KR |
|
A
|
Australia and New Zealand Banking Group Ltd
NZX:ANZ
|
AU |
|
CAC Holdings Corp
TSE:4725
|
JP |
|
Pacira Biosciences Inc
NASDAQ:PCRX
|
US |
Wall St Price Targets
HBIO Price Targets Summary
Harvard Bioscience Inc
According to Wall Street analysts, the average 1-year price target for
HBIO is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HBIO's stock price target?
Price Target
6.12
USD
According to Wall Street analysts, the average 1-year price target for
HBIO is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.
What is the Revenue forecast for Harvard Bioscience Inc?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 2 years is 5%.